Verition Fund Management »

Lenz Therapeutics shares owned by Verition Fund Management

Quarter-by-quarter ownership of Lenz Therapeutics (LENZ) shares owned by Verition Fund Management from 13F filings

Historical chart of Verition Fund Management investment in Lenz Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lenz Therapeutics held by Verition Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lenz Therapeutics by Verition Fund Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $740k 46k 16.00
2025-03-31 $709k 28k 25.71

More positions owned by Verition Fund Management

NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Tesla Motors (TSLA)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Warner Bros Discovery Com Ser A (WBD)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Microsoft Corporation (MSFT)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Electronic Arts (EA)
Ishares Tr Russell 2000 Etf (IWM)
Palantir Technologies Cl A (PLTR)
Micron Technology (MU)

View all positions for Verition Fund Management

Top funds holding Lenz Therapeutics

RA Capital Management
Falcon Edge Capital
Versant Venture Management
UBS Group
BlackRock
Vanguard Group
Franklin Resources
72 Investment Holdings
Tang Capital Management
Adage Capital Partners GP
Intrinsic Edge Capital Management
State Street Corporation
CAM Group Holding A/S
Squarepoint Ops
Standard Life Aberdeen

View all funds holding Lenz Therapeutics